Literature DB >> 1779252

Acute motor neuropathy with antibodies to GM1 ganglioside.

N A Gregson1, D Jones, P K Thomas, H J Willison.   

Abstract

We describe a 52-year-old man who had an acute-onset purely motor neuropathy fulfilling the diagnostic criteria for the Guillain-Barré syndrome, in whom virtually complete spontaneous recovery occurred by 1 year, and in whom high titres of polyclonal serum antibody to GM1, GD1b, asialo-GM1 and lacto-N-tetraose were detected. The titre of IgM antibody to GM1 fell during the course of the disease with a concomitant rise in the IgG titre. This case adds to the widening spectrum of disease associated with anti-GM1 antibodies and provides further evidence for a relationship between anti-GM1 antibodies and motor system disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1779252     DOI: 10.1007/bf00314652

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

Review 1.  Antibody detection in Guillain-Barré syndrome.

Authors:  L Svennerholm; P Fredman
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

2.  Localization of neural epitopes that bind to IgM monoclonal autoantibodies (M-proteins) from two patients with motor neuron disease.

Authors:  F P Thomas; P H Adapon; G P Goldberg; N Latov; A P Hays
Journal:  J Neuroimmunol       Date:  1989-01       Impact factor: 3.478

3.  Monoclonal IgMs with anti-Gal(beta 1-3) GalNAc activity in lower motor neuron disease; identification of glycoprotein antigens in neural tissue and cross-reactivity with serum immunoglobulins.

Authors:  F P Thomas; A M Lee; S N Romas; N Latov
Journal:  J Neuroimmunol       Date:  1989-07       Impact factor: 3.478

4.  Measurement and significance of antibodies against GM1 ganglioside. Report of a workshop, 18 April 1989, Chicago, IL, U.S.A.

Authors:  D M Marcus; N Latov; B P Hsi; B K Gillard
Journal:  J Neuroimmunol       Date:  1989-12       Impact factor: 3.478

5.  A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside.

Authors:  A Pestronk; D R Cornblath; A A Ilyas; H Baba; R H Quarles; J W Griffin; K Alderson; R N Adams
Journal:  Ann Neurol       Date:  1988-07       Impact factor: 10.422

6.  An acute axonal form of Guillain-Barré polyneuropathy.

Authors:  T E Feasby; J J Gilbert; W F Brown; C F Bolton; A F Hahn; W F Koopman; D W Zochodne
Journal:  Brain       Date:  1986-12       Impact factor: 13.501

7.  Polyneuropathy with monoclonal gammopathy: glycolipids are frequently antigens for IgM paraproteins.

Authors:  A A Ilyas; R H Quarles; M C Dalakas; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

8.  Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis.

Authors:  A Pestronk; R N Adams; L Clawson; D Cornblath; R W Kuncl; D Griffin; D B Drachman
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

Review 9.  Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system.

Authors:  R H Quarles; A A Ilyas; H J Willison
Journal:  Chem Phys Lipids       Date:  1986-12-15       Impact factor: 3.329

10.  Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b.

Authors:  E Nardelli; A J Steck; T Barkas; M Schluep; F Jerusalem
Journal:  Ann Neurol       Date:  1988-05       Impact factor: 10.422

View more
  14 in total

1.  Gangliosides and neurological diseases.

Authors:  P O Behan; B A Haniffah
Journal:  BMJ       Date:  1992-11-28

2.  Coupling of nerve growth factor to its receptor: inhibition by anti-GM3 ganglioside antibody.

Authors:  M Chakraborty; D Chatterjee
Journal:  Cell Mol Neurobiol       Date:  2001-02       Impact factor: 5.046

Review 3.  Guillain-Barré syndrome: a century of progress.

Authors:  John A Goodfellow; Hugh J Willison
Journal:  Nat Rev Neurol       Date:  2016-11-18       Impact factor: 42.937

Review 4.  Antiglycolipid antibodies in peripheral neuropathy: fact or fiction?

Authors:  H J Willison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

5.  A comparative trial of anti-glycoconjugate antibody assays: IgM antibodies to GM1.

Authors:  J Zielasek; G Ritter; S Magi; H P Hartung; K V Toyka
Journal:  J Neurol       Date:  1994-07       Impact factor: 4.849

6.  Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN1a).

Authors:  C M Gabriel; N A Gregson; N W Wood; R A C Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

7.  Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.

Authors:  C W Ang; M A De Klerk; H P Endtz; B C Jacobs; J D Laman; F G van der Meché; P A van Doorn
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

8.  Guillain-Barré syndrome associated with IgM anti-GM1 antibody following Campylobacter jejuni enteritis.

Authors:  K Sugita; M Ishii; J Takanashi; H Niimi; N Yuki
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

9.  The Guillain-Barré syndrome: no longer a simple concept.

Authors:  P K Thomas
Journal:  J Neurol       Date:  1992-08       Impact factor: 4.849

10.  Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside.

Authors:  H J Willison; J Veitch; G Paterson; P G Kennedy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.